Rymarz Zdort Maruta advises GKSD and Gruppo San Donato on acquisition of majority equity stake in American Heart of Poland

We are pleased to announce that we advised GKSD S.r.l. (“GKSD”) and Gruppo San Donato (“GSD”) in connection with their joint acquisition of a majority stake in American Heart of Poland S.A. (“AHP”). The transaction will create a leader in cardiovascular disease treatment in Europe and will lead to the advancement of quality healthcare, healthcare research and medical education on the continent. The transaction remains subject to the granting of clearance by the Office of Competition and Consumer Protection in Poland.

“We are delighted to have advised GKSD and GSD on this strategic transaction, which marks the beginning of their presence on the Polish market. This transaction perfectly illustrates the potential of the healthcare sector in Poland and also demonstrates the strength of our M&A practice and its ability to provide successful, innovative and comprehensive legal advice to clients operating in the healthcare sector,” said Paweł Zdort, a managing partner and a co-head of the Corporate/M&A practice, who also led the team.

GKSD manages a diverse portfolio of operating companies in Italy that generates added value for its stakeholders by leveraging its unique know-how. GKSD focuses on a number of sectors, including real estate, engineering, energy, procurement and healthcare advisory services.

GSD is Italy’s largest private healthcare group and the leading European healthcare group specialising in acute care, medical education and research. With 56 medical sites, world-leading teaching and research hospitals, a university (Vita Salute San Raffaele University, with 22 masters’ programmes and providing PhD-level education) as well as medical research ranking in the top 10 globally (by medical research citations), Gruppo San Donato is a global pioneer of gene and cell therapy. GSD treats over 5.4 million patients a year, performing over 14 million procedures and employing over 27,000 medical professionals.

AHP is the largest independent provider of comprehensive cardiovascular care in Europe and one of the largest private healthcare providers in Poland, with a focus on supporting the public healthcare system. It has been recognised for achieving the highest standards of quality through a skilled workforce comprising trained medical experts. With 77 sites (20 cardiology wards, 2 vascular surgery wards, 4 rehabilitation clinics, 22 outpatient clinics, and numerous diagnostic and lab points) supported by more than 3,780 skilled staff members, including 1,200 doctors, the group remains focused on supporting the public healthcare system in Poland. AHP specialises in treating diseases suffered by our ageing society through the use of a variety of care options, including complex operations, a number of rehabilitation programmes, and outpatient and diagnostic care. It is a partner of the Ministry of Health and the National Health Fund. 

Rymarz Zdort Maruta provided comprehensive legal advice. The transaction team included: Paweł Zdort (managing partner), Iwona Her (partner), Bartosz Romanowski (partner), Irmina Wątły (counsel), Małgorzata Deruś (senior associate), Aleksandra Kabać (senior associate), Szymon Rutecki (associate), Jakub Wilk (associate) and Justyna Niezgoda (associate).